Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | PTGES2 | Q9H7Z7 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 3/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.43 |
| ▸ | WDR5 | P61964 | 2/20 | 0.42 |
| ▸ | MYC | P01106 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31556387 | 1.00 | PKM (0.53) | PKMSMN1; SMN2TSHRGLAPTGES2 | |
| SCHEMBL1137871 | 0.85 | SMN1; SMN2 (0.59) | PKMSMN1; SMN2TSHRGLAPTGES2 | |
| Hydrochloric Acid SCHEMBL27865616 | 0.84 | SMN1; SMN2 (0.58) | PKMSMN1; SMN2TSHRGLAPTGES2 | |
| Methane SCHEMBL25341724 | 0.84 | SMN1; SMN2 (0.58) | PKMSMN1; SMN2TSHRGLAPTGES2 | |
| SCHEMBL4573199 | 0.83 | SMN1; SMN2 (0.50) | SMN1; SMN2TSHRGLAGAATRPV4 | |
| SCHEMBL4018384 | 0.81 | TRPV4 (0.66) | SMN1; SMN2TSHRGLAGAATRPV4 | |
| SCHEMBL17315165 | 0.81 | SMN1; SMN2 (0.47) | SMN1; SMN2TSHRGLALMNAGAA | |
| SCHEMBL20505498 | 0.81 | LMNA (0.57) | PKMSMN1; SMN2TSHRGLALMNA | |
| SCHEMBL31050364 | 0.80 | SMN1; SMN2 (0.46) | SMN1; SMN2TSHRGLAGAATRPV4 | |
| SCHEMBL51171 | 0.79 | MCOLN3 (0.55) | PKMSMN1; SMN2TSHRPTGES2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099404-A1 | SULFONYLUREA DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER | QUBIT PHARMACEUTICALS (FR) | 2026-05-15 | — | — | WO | disclosed |
| EP-4741375-A1 | SULFONYLUREA DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER | Qubit Pharmaceuticals (FR) | 2026-05-13 | — | — | EP | disclosed |
| EP-4727939-A1 | 5-(CINNOLIN-6-YL)THIAZOLE COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS | Prothena Biosciences Limited (IE) | 2026-04-22 | — | — | EP | disclosed |
| US-20250122152-A1 | KAT6 Inhibitors | BEIGENE SWITZERLAND GMBH (CH) | 2025-04-17 | — | — | US | disclosed |
| WO-2024259116-A1 | 5-(CINNOLIN-6-YL)THIAZOLE COMPOUNDS FOR TREATING NEUROLOGICAL DISORDERS | PROTHENA BIOSCIENCES LIMITED (IE) | 2024-12-19 | — | — | WO | disclosed |
| EP-2774916-B1 | PHENOLSULFONIC ACID ARYL ESTER, DEVELOPING AGENT, AND HEAT-SENSITIVE RECORDING MATERIAL | JUJO PAPER CO LTD (JP) | 2016-05-25 | — | — | EP | disclosed |
| US-9073376-B2 | Phenolsulfonic acid aryl ester, developing agent, and heat-sensitive recording material | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 2015-07-07 | — | — | US | disclosed |
| US-20140315713-A1 | PHENOLSULFONIC ACID ARYL ESTER, DEVELOPING AGENT, AND HEAT-SENSITIVE RECORDING MATERIAL | NIPPON PAPER INDUSTRIES CO., LTD. (JP) | 2014-10-23 | — | — | US | disclosed |
| EP-2774916-A1 | PHENOLSULFONIC ACID ARYL ESTER, DEVELOPING AGENT, AND HEAT-SENSITIVE RECORDING MATERIAL | Nippon Paper Industries Co., Ltd. (JP) | 2014-09-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140315713-A1 | PHENOLSULFONIC ACID ARYL ESTER, DEVELOPING AGENT, AND HEAT-SENSITIVE RECORDING MATERIAL | ARSA, AHNAK, HSPA4L | PKM 3520/4885SMN1; SMN2 1242/4885TSHR 4347/4885 |
| US-20250122152-A1 | KAT6 Inhibitors | KAT6A, KAT6B, KAT7 | PKM 1693/4885SMN1; SMN2 1499/4885TSHR 3646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.